Preoperative Panitumumab and Radiotherapy in Rectal Cancer

Stopped The intermediate analyses did not allowed to continue the clinical study.

Conditions

• Rectal Cancer

Interventions

• DRUG: panitumumab

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain